AYTU BIOPHARMA, INC Other Labor-related Expenses
AYTU BIOPHARMA, INC (AYTU) reported Other Labor-related Expenses of $264.00 thousand for the 6-month period ending 2015-12-31, per its 10-Q filed 2016-02-11.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherLaborRelatedExpenses · last filed 2016-02-11
- AYTU BIOPHARMA, INC other labor-related expenses for the quarter ending 2015-12-31 was $0.00.
- AYTU BIOPHARMA, INC other labor-related expenses for the quarter ending 2015-09-30 was $264.00K, a 4.35% increase year-over-year.
- AYTU BIOPHARMA, INC other labor-related expenses for the quarter ending 2014-12-31 was $0.00.
- AYTU BIOPHARMA, INC other labor-related expenses for the quarter ending 2014-09-30 was $253.00K.
- AYTU BIOPHARMA, INC other labor-related expenses for fiscal 2015 was $264.00K, a 4.35% increase from fiscal 2014.
- AYTU BIOPHARMA, INC other labor-related expenses for fiscal 2014 was $253.00K.
| Period end | Other Labor-related Expenses 3 month | Other Labor-related Expenses 6 month | Other Labor-related Expenses 12 month |
|---|---|---|---|
| 2015-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-11 | $264.00K 10-Q · filed 2016-02-11 | |
| 2015-09-30 | $264.00K 10-Q · filed 2015-11-06 | ||
| 2015-06-30 | $264.00K 10-K · filed 2015-09-28 | ||
| 2014-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-11 | $253.00K 10-Q · filed 2016-02-11 | |
| 2014-09-30 | $253.00K 10-Q · filed 2015-11-06 | ||
| 2014-06-30 | $253.00K 10-K · filed 2015-09-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |